Stick a fork in 'em – The 2009 Diamondbacks

0 Comments

While they have a slightly better record than the Indians, the
Diamondbacks are the second team we’re declaring dead for 2009.
Wednesday’s loss dropped them 18 1/2 games back in the NL West. Even
the lowly Nationals, the recipient of the first fork of the year, are a mere 17 1/2 games in the NL East.

So, let’s examine what the D’backs can look forward to in 2010.

The 2010 depth chart

Catcher: Chris Snyder, Miguel Montero (Arb.), Orlando Mercado, James Skelton

If they hadn’t been so stubborn about holding out for Michael Bowden,
the Diamondbacks very likely could have had Daniel Bard from the Red
Sox for Montero over the winter. Unfortunately, they probably wouldn’t
do so well now. Montero hasn’t progressed in an expanded role first
brought upon by the managerial switch to A.J. Hinch and then enhanced
further by Snyder’s recent DL stint.

The team could instead opt to move Snyder, who will make $10.5 million
between 2010 and 2011, but they’d be fortunate to receive more than a
couple of B prospects back. Since there aren’t any assurances that
Montero will be a quality regular and none of the team’s prospects
project as starters, standing pat may well be the best strategy.

First base: Conor Jackson (Arb.), Mark Reynolds, Josh Whitesell

Whitesell is a quad-A player and Chad Tracy is a free agent, so the
Diamondbacks could either turn Reynolds into a first baseman or look
outside of the organization for a solution this winter. My guess is
that they’ll leave Reynolds at third, given that he has the range for
the position and he’s been even more error-prone than usual while
playing first base this year. Jackson has appeared to be more valuable
defensively in left field than he was at first base. More on him below.

Second base: Ryan Roberts, Augie Ojeda (Arb.), Rusty Ryal, Ruben Gotay, Mark Hallberg, James Skelton

Yes, it’s that bleak. Ryan, a 26-year-old hitting .286/.345/.500 in
the PCL, figures to get a look at second base if the Diamondbacks trade
free-agent-to-be Felipe Lopez. However, he should be nothing more than
a fallback option again in 2009. Since Hallberg hasn’t hit in Double-A,
the Diamondbacks should be in the market for a veteran second baseman
for the second year in a row. Fortunately, decent ones are usually
pretty easy to find.

Third base: Mark Reynolds, Augie Ojeda (Arb.), Ryan Roberts

If the Diamondbacks did move Reynolds across the diamond, they’d
just have to go after a replacement at third instead. The club did
draft third basemen with the 16th and 35th selections in the 2009 draft
(Bobby Borchering and Matt Davidson), but both were high school players
and neither will move quickly.

Shortstop: Stephen Drew (Arb.), Augie Ojeda, Pedro Ciriaco

One of the few positives for the Diamondbacks this year is that
Drew’s fielding numbers have been considerably better than they were
last year. I could see an argument for moving Drew to third and
Reynolds to first, but it’s not something with any chance of happening
in the near future. Besides, the Diamondbacks don’t have a Elvis Andrus
to break in at short.

Left field: Conor Jackson (Arb.), Gerardo Parra, Eric Byrnes, Trent Oeltjen, Cyle Hankerd, Collin Cowgill

Center field: Chris Young, Gerardo Parra, Eric Byrnes

Right field: Justin Upton, Gerardo Parra, Eric Byrnes

We know Upton is a fixture in right. The Diamondbacks will have to
decide whether it’s worth trading Young or moving Jackson back to first
base to make room for Parra in the 2010 outfield. The 22-year-old Parra
got off to a very nice start after coming up as Jackson’s replacement
this year, but he’s now sporting a .259/.302/.400 line and given that
he’s never played in Triple-A, he still might need some additional
seasoning.

Complicating things is that both Young and Jackson have lost a great
deal of trade value. Young showed clear signs of bouncing back from a
horrendous start last month, but he’ll have to keep it up if the
Diamondbacks are going to get fair value for him this season.
Unfortunately, it looks like Jackson’s season has been completely
ruined by his case of valley fever, but at least that means he’s not
going to receive much of a raise from his current $3 million salary.

The Diamondbacks are almost certainly stuck with Byrnes, who figures to remain an $11 million fourth outfielder.

I think a Jackson-Young-Upton outfield will be the best option at
the beginning of 2010. However, Parra would likely guarantee himself a
spot with a strong second half.

Rotation: Brandon Webb (option), Dan Haren, Max Scherzer, Jon
Garland (option), Jarrod Parker, Yusmeiro Petit, Esmerling Vasquez,
Cesar Valdez, Billy Buckner, Bryan Augenstein, Barry Enright

If Webb can come back from his shoulder problems in September, then the
$6 million decision on his 2010 option will remain an easy call. Still,
it’s not like the Diamondbacks will be able to pencil him in for 220
innings next year.

The uncertainty around Webb is probably the one thing that could
cause the Diamondbacks to listen to offers for Haren. A team with a
Webb-Haren-Scherzer front three should be capable of competing next
year. However, if the Diamondbacks suddenly learned that Webb needed
surgery that would cost him at least part of next year, they’d have to
give serious thought to cashing in Haren for the huge return he’d bring
in. He’s under control through 2013 at fairly reasonable terms.

The Diamondbacks, though, won’t really know about Webb’s health
until the final month, making a Haren deadline deal awfully unlikely.

Doug Davis is a free agent and is likely to be traded. Garland is on
a mutual option, making it unlikely that he’ll be back. Ideally, the
Diamondbacks will replace him with a similar fourth-starter type and
then get by with a Petit or Valdez in the fifth spot until Parker
arrives. He could be next year’s Tommy Hanson.

Bullpen: Chad Qualls, Tony Pena (Arb.), Jon Rauch, Juan Gutierrez,
Daniel Schlereth, Clay Zavada, Esmerling Vasquez, Billy Buckner,
Yusmeiro Petit, Blaine Boyer (Arb.), Daniel Strange, Bobby Korecky,
Doug Slaten, Leo Rosales, Jose Marte, Kyler Newby

Qualls is only under control through 2010 and could receive a raise to
$4.5 million-$5 million in arbitration after spending a full year as a
closer, so he might be the Diamondback most likely to go in a deadline
deal. Rauch, now that he’s past his early-season woes, is next in line.
That would potential leave Pena as the Diamondbacks’ closer, though he
hasn’t made a particularly strong case for the role while posting a
4.36 ERA this season. Gutierrez would be another option. Schlereth, a
left-hander picked in the first round last year, is the best bet for
the long-term. If the Diamondbacks do move Qualls, they’ll probably
look for a cheap veteran to serve as a stopgap closer next year.

Time for a best guess:

Arizona’s 2010 roster

Lineup

2B Free agent

SS Stephen Drew

RF Justin Upton

3B Mark Reynolds

1B Free agent

LF Conor Jackson

CF Chris Young

C Chris Snyder

Bench: OF Eric Byrnes, C Miguel Montero, INF Augie Ojeda, INF Ryan Roberts, OF Free agent

Rotation

Dan Haren

Brandon Webb

Max Scherzer

Free agent

Cesar Valdez

Bullpen

Free agent

Tony Pena

Juan Gutierrez

Clay Zavada

Free agent

Esmerling Vasquez

Billy Buckner

Ideally, the Diamondbacks will get their answer at first, second or
in the rotation in return for Davis later this month. Qualls could also
bring back someone capable of playing an important role on the 2010
club. There probably won’t be a whole lot of money available after
raises for Drew, Young, Haren and Snyder kick in. One huge factor in
how much flexibility the Diamondbacks will have is whether Reynolds
qualifies as a super-two player. He’ll have two years and 138 days of
service time at season’s end. Last year, Taylor Buchholz was the last
player to qualify as a super two and he had two years, 140 days. With
the season Reynolds is having, it could be a $5 million swing for the
Diamondbacks.

Jacob deGrom, oft-injured Rangers ace, to have season-ending right elbow surgery

rangers degrom
Charles LeClaire/USA TODAY Sports
2 Comments

ARLINGTON, Texas — The Texas Rangers signed Jacob deGrom to a $185 million, five-year deal in free agency last winter hoping the two-time NL Cy Young Award winner could help them get back to the playoffs for the first time since 2016 and make a push toward winning a World Series.

They also knew the risks, with the pitcher coming off two injury-plagued seasons with the New York Mets.

Even with deGrom sidelined since late April, the AL West-leading Rangers are off to the best start in franchise history – but now will be without their prized acquisition until at least next year. The team said Tuesday that deGrom will have season-ending surgery next week to repair a torn ulnar collateral ligament in his right elbow.

“We’ve got a special group here and to not be able to be out there and help them win, that stinks,” deGrom said, pausing several times with tears in his eyes. “Wanting to be out there and helping the team, it’s a disappointment.”

General manager Chris Young said Tuesday the decision on surgery came after an MRI on deGrom’s ailing right elbow, but the extent of what is required might not be determined until the operation is performed next week.

Tommy John surgery, in which the damaged ligament is replaced, is often needed to fix a torn UCL, but Young and the Rangers didn’t go as far as saying the pitcher would have that particular procedure. After being drafted by the New York Mets in 2010, deGrom made six starts in the minors that summer before needing Tommy John surgery and missing all of 2011, three years before his big league debut.

DeGrom last pitched April 28 against the New York Yankees, when he exited early because of injury concerns for the second time in a span of three starts. The announcement about surgery came a day after deGrom was transferred to the 60-day injured list.

Young said the latest MRI showed more inflammation and significant structural damage in the ligament that wasn’t there on the scan after deGrom left the game against the Yankees.

“The results of that MRI show that we have not made progress. And in fact, we’ve identified some damage to the ligament,” Young said. “It’s obviously a tough blow for Jacob, for certainly the Rangers. But we do feel this is what is right for Jacob in his career. We’re confident he’ll make a full recovery.”

Young and deGrom, who turns 35 later this month, said the goal is for the pitcher to return near the end of next season. Both said they were glad to have clarity on what was wrong with the elbow.

Texas won all six games started by deGrom (2-0), but the right-hander threw only 30 1/3 innings. He has a 2.67 ERA with 45 strikeouts and four walks. He threw 3 2/3 scoreless innings against the Yankees in his last start before leaving because of discomfort in his arm.

The Rangers went into Tuesday night’s game against St. Louis with a 39-20 record, the first time they were 19 games over .500 since the end of 2016, their last winning season.

Before going home to Florida over the weekend for the birth of his third child, deGrom threw his fifth bullpen last Wednesday in Detroit.

“I’d have days where I’d feel really good, days where I didn’t feel great. So I was kind of riding a roller coaster there for a little bit,” deGrom said. “They said originally there, we just saw some inflammation. … Getting an MRI right after you pitch, I feel like anybody would have inflammation. So, you know, I was hoping that that would get out of there and I would be fine. But it just didn’t work out that way.”

DeGrom spent his first nine big league seasons with the Mets, but was limited by injuries to 156 1/3 innings over 26 starts during his last two years in New York.

He had a career-low 1.08 ERA over 92 innings in 2021 before missing the final three months of the season with right forearm tightness and a sprained elbow.

The four-time All-Star didn’t make his first big league start last year until Aug. 2 after being shut down late in spring training because of a stress reaction in his right scapula.

His latest injury almost surely will trigger Texas’ conditional option on deGrom’s contract for 2028.

The option takes effect if deGrom has Tommy John surgery on his right elbow from 2023-26 or has any right elbow or shoulder injury that causes him to be on the IL for any period of 130 consecutive days during any season or 186 days in a row during any service period.

The conditional option would be for $20 million, $30 million or $37 million, depending on deGrom’s performance during the contract and health following the 2027 season.

“I feel bad for Jake. If I know Jake, he’ll have the surgery and come back and finish his career strong,” second-year Mets manager Buck Showalter said. “I know how much it means to him. He enjoys pitching. It’s certainly sad news for all of us.”